# Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment

> **NCT03326505** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Jordan** · enrollment: 60 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **BIOLOGICAL:** Umbilical cord derived Mesenchymal Stem Cells
- **OTHER:** Supervised physical therapy

## Key facts

- **NCT ID:** NCT03326505
- **Lead sponsor:** University of Jordan
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-25
- **Primary completion:** 2020-01-25
- **Final completion:** 2020-02-20
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03326505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03326505, "Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03326505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*